NCT02486835

Brief Summary

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. The intent of this study is to use a protective syrup with does not act as a sedative or as a potent mucolytic and measure its efficacy and safety versus placebo in children with moderate to severe night and daily cough. Cough is assessed with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 1, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

December 23, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2016

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2016

Completed
Last Updated

January 29, 2018

Status Verified

January 1, 2018

Enrollment Period

3 months

First QC Date

May 17, 2015

Last Update Submit

January 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in night cough frequency score in the general population

    Night cough frequency is the most invasive element of distress to the child and family. The questionnaire rating night cough is filled in each morning relating to the passed night for four nights. The basal night score is the score of the night before enrollment.

    baseline up to night 1

Secondary Outcomes (14)

  • Change in night cough frequency score in the population coughing since 1-2 days

    baseline up to night 1

  • Change in night cough frequency score in the female population coughing since 1-2 days

    baseline up to night 1

  • Change in night cough frequency score in the male population coughing since 1-2 days

    baseline up to night 1

  • Change in night cough severity score in the general population

    baseline up to night 1

  • Change in night cough severity score in the population coughing since 1-2 days

    baseline up to night 1

  • +9 more secondary outcomes

Study Arms (2)

"Cough Syrup for adults and children"

EXPERIMENTAL

Marked (authorized) medical device acting by protecting the oropharynx, in a non pharmacological way, to reduce cough. It contains honey, plantago lanceolata, thymus vulgaris.Dosage form: syrup Dosage: 5 ml three times a day. Frequency: the duration of the study for each patient is 4 nights, 3 days.

Device: Cough syrup for adults and children

Placebo

PLACEBO COMPARATOR

The placebo intervention is a syrup of same taste and colour without the protective components. Dosage form: syrup. Dosage: 5 ml three times a day Frequency: the duration of the study for each patient is 4 nights, 3 days.

Device: Placebo

Interventions

Dosage is 5 ml three times a day for 4 nights, 3 days

Also known as: Poliflav M.A.-honey cough syrup
"Cough Syrup for adults and children"
PlaceboDEVICE

Dosage is 5 ml three times a day for 4 nights, 3 days

Placebo

Eligibility Criteria

Age1 Year - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • cough attributed to infection of the upper respiratory tract since less or equal than 7 days,
  • children aged 1 to 5 years
  • score of three or more of al least two of the following three questions relating to night cough, frequency of nocturnal cough, impact on sleep of child and impact on sleep of parent,
  • score of at least three of all questions assessing daytime cough considering the day prior to study entry
  • written consent by a parent.

You may not qualify if:

  • Children with a diagnosis of acute laryngotracheal bronchitis, pneumonia, asthma, sinusitis, allergic rhinitis, as well as chronic cardiac condition, or cystic fibrosis or any anatomical respiratory tract anomalies,
  • Children who received antihistamines or any cough medicine the day prior to study entry,
  • The administration of any steroid preparation by oral administration or inhalation on the day prior to study entry,
  • Known sensitivity to any component of placebo or to Plantago lanceolata or Thymus vulgaris, honey or any other component of the cough syrup.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Pediatric Ambulatory Clinic Bat-Yam

Bat Yam, Israel

Location

Pediatric Ambulatory Clinic Kfar-Saba

Kfar Saba, Israel

Location

Pediatric Community Ambulatory Clinic - Petach-Tikva

Petah Tikva, Israel

Location

Pediatric Ambulatory Clinic Ramat Aviv Gimel

Tel Aviv, Israel

Location

Related Publications (9)

  • Middleton KR, Hing E. National Hospital Ambulatory Medical Care Survey: 2004 outpatient department summary. Adv Data. 2006 Jun 23;(373):1-27.

    PMID: 16841784BACKGROUND
  • Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, Dilworth DA, Berlin CM Jr. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004 Jul;114(1):e85-90. doi: 10.1542/peds.114.1.e85.

    PMID: 15231978BACKGROUND
  • Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007 Dec;161(12):1140-6. doi: 10.1001/archpedi.161.12.1140.

    PMID: 18056558BACKGROUND
  • Wegener T, Kraft K. [Plantain (Plantago lanceolata L.): anti-inflammatory action in upper respiratory tract infections]. Wien Med Wochenschr. 1999;149(8-10):211-6. German.

    PMID: 10483683BACKGROUND
  • Canciani M, Murgia V, Caimmi D, Anapurapu S, Licari A, Marseglia GL. Efficacy of Grintuss(R) pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial. Ital J Pediatr. 2014 Jun 10;40:56. doi: 10.1186/1824-7288-40-56.

    PMID: 24917119BACKGROUND
  • Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics. 2008 Aug;122(2):e318-22. doi: 10.1542/peds.2007-3813.

    PMID: 18676517BACKGROUND
  • Schramm DD, Karim M, Schrader HR, Holt RR, Cardetti M, Keen CL. Honey with high levels of antioxidants can provide protection to healthy human subjects. J Agric Food Chem. 2003 Mar 12;51(6):1732-5. doi: 10.1021/jf025928k.

    PMID: 12617614BACKGROUND
  • Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: a review. J Am Coll Nutr. 2008 Dec;27(6):677-89. doi: 10.1080/07315724.2008.10719745.

    PMID: 19155427BACKGROUND
  • Cohen HA, Rozen J, Kristal H, Laks Y, Berkovitch M, Uziel Y, Kozer E, Pomeranz A, Efrat H. Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study. Pediatrics. 2012 Sep;130(3):465-71. doi: 10.1542/peds.2011-3075. Epub 2012 Aug 6.

    PMID: 22869830BACKGROUND

MeSH Terms

Conditions

Cough

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Herman A Cohen, Prof.

    Clalit HS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Herman Avner Cohen

Study Record Dates

First Submitted

May 17, 2015

First Posted

July 1, 2015

Study Start

December 23, 2015

Primary Completion

April 3, 2016

Study Completion

April 6, 2016

Last Updated

January 29, 2018

Record last verified: 2018-01

Locations